{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:56:48Z","timestamp":1791219408234,"version":"4.1.0"},"reference-count":61,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T00:00:00Z","timestamp":1646006400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Radiation Oncology Private Practice Trust Fund"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Clinical adoption of immune checkpoint inhibitors in cancer management has highlighted the interconnection between carcinogenesis and the immune system. Immune cells are integral to the tumour microenvironment and can influence the outcome of therapies. Better understanding of an individual\u2019s immune landscape may play an important role in treatment personalisation. Peripheral blood is a readily accessible source of information to study an individual\u2019s immune landscape compared to more complex and invasive tumour bioipsies, and may hold immense diagnostic and prognostic potential. Identifying the critical components of these immune signatures in peripheral blood presents an attractive alternative to tumour biopsy-based immune phenotyping strategies. We used two syngeneic solid tumour models, a 4T1 breast cancer model and a CT26 colorectal cancer model, in a longitudinal study of the peripheral blood immune landscape. Our strategy combined two highly accessible approaches, blood leukocyte immune phenotyping and plasma soluble immune factor characterisation, to identify distinguishing immune signatures of the CT26 and 4T1 tumour models using machine learning. Myeloid cells, specifically neutrophils and PD-L1-expressing myeloid cells, were found to correlate with tumour size in both the models. Elevated levels of G-CSF, IL-6 and CXCL13, and B cell counts were associated with 4T1 growth, whereas CCL17, CXCL10, total myeloid cells, CCL2, IL-10, CXCL1, and Ly6C<jats:sup>intermediate<\/jats:sup> monocytes were associated with CT26 tumour development. Peripheral blood appears to be an accessible means to interrogate tumour-dependent changes to the host immune landscape, and to identify blood immune phenotypes for future treatment stratification.<\/jats:p>","DOI":"10.1371\/journal.pone.0264631","type":"journal-article","created":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T18:28:28Z","timestamp":1646072908000},"page":"e0264631","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Machine learning predicts cancer subtypes and progression from blood immune signatures"],"prefix":"10.1371","volume":"17","author":[{"given":"David A.","family":"Simon Davis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahngeun","family":"Mun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julianne M.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dillon","family":"Hammill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Garrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine","family":"Gosling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2083-4961","authenticated-orcid":true,"given":"Hany","family":"Elsaleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhan M.","family":"Syed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines I.","family":"Atmosukarto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2938-5007","authenticated-orcid":true,"given":"Benjamin J. C.","family":"Quah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,2,28]]},"reference":[{"key":"pone.0264631.ref001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mrrev.2018.05.001","article-title":"Multiclonal tumor origin: Evidence and implications","volume":"777","author":"B. L. Parsons","year":"2018","journal-title":"Mutat. Res. Rev. Mutat. Res."},{"issue":"6","key":"pone.0264631.ref002","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41568-021-00347-z","article-title":"Systemic immunity in cancer","volume":"21","author":"K. J. Hiam-Galvez","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"7","key":"pone.0264631.ref003","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/s41591-020-0892-6","article-title":"Systemic dysfunction and plasticity of the immune macroenvironment in cancer models","volume":"26","author":"B. M. Allen","year":"2020","journal-title":"Nat. Med."},{"issue":"6","key":"pone.0264631.ref004","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41422-020-0337-2","article-title":"The future of cancer immunotherapy: microenvironment-targeting combinations","volume":"30","author":"Y. R. Murciano-Goroff","year":"2020","journal-title":"Cell Res."},{"issue":"1","key":"pone.0264631.ref005","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.immuni.2019.12.011","article-title":"Top 10 Challenges in Cancer Immunotherapy","volume":"52","author":"P. S. Hegde","year":"2020","journal-title":"Immunity"},{"issue":"1","key":"pone.0264631.ref006","doi-asserted-by":"crossref","DOI":"10.1038\/nrc1252","article-title":"Cytokines in cancer pathogenesis and cancer therapy","volume":"4","author":"G. Dranoff","year":"2004","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"pone.0264631.ref007","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.immuni.2021.01.012","article-title":"Chemokines and the immune response to cancer","volume":"54","author":"A. J. Ozga","year":"2021","journal-title":"Immunity"},{"issue":"10","key":"pone.0264631.ref008","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41551-018-0304-0","article-title":"Explainable machine-learning predictions for the prevention of hypoxaemia during surgery","volume":"2","author":"S. M. Lundberg","year":"2018","journal-title":"Nat. Biomed. Eng."},{"issue":"5","key":"pone.0264631.ref009","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2613.2007.00539.x","article-title":"The mouse mammary carcinoma 4T1: characterization of the cellular landscape of primary tumours and metastatic tumour foci","volume":"88","author":"Int","year":"2007","journal-title":"J. Exp. Pathol."},{"key":"pone.0264631.ref010","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3389\/fonc.2020.01195","article-title":"Multi-Omics Characterization of the 4T1 Murine Mammary Gland Tumor Model","volume":"10","author":"B. Schr\u00f6rs","year":"2020","journal-title":"Front. Oncol."},{"issue":"11","key":"pone.0264631.ref011","article-title":"Tumor-immune profiling of murine syngeneic tumor models as a framework to guide mechanistic studies and predict therapy response in distinct tumor microenvironments","volume":"13","author":"J. W. Yu","year":"2018","journal-title":"PLoS ONE"},{"issue":"1","key":"pone.0264631.ref012","doi-asserted-by":"crossref","DOI":"10.1186\/s12864-019-6344-3","article-title":"Comparison of the molecular and cellular phenotypes of common mouse syngeneic models with human tumors","volume":"21","author":"W. Zhong","year":"2020","journal-title":"BMC Genomics"},{"issue":"1","key":"pone.0264631.ref013","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/A:1010933404324","article-title":"Random Forests","volume":"45","author":"L. Breiman","year":"2001","journal-title":"Mach. Learn."},{"issue":"1","key":"pone.0264631.ref014","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s12935-021-01981-1","article-title":"Clinical applications of artificial intelligence and machine learning in cancer diagnosis: looking into the future","volume":"21","author":"M. J. Iqbal","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"2","key":"pone.0264631.ref015","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3390\/jcm10020301","article-title":"Early Detection of Septic Shock Onset Using Interpretable Machine Learners","volume":"10","author":"D. Misra","year":"2021","journal-title":"J. Clin. Med."},{"issue":"1","key":"pone.0264631.ref016","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1038\/s41598-020-74399-w","article-title":"Multimodal deep learning models for early detection of Alzheimer\u2019s disease stage","volume":"11","author":"J. Venugopalan","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"pone.0264631.ref017","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1080\/21642583.2014.956265","article-title":"Random forests: from early developments to recent advancements","volume":"2","author":"K. Fawagreh","year":"2014","journal-title":"Syst. Sci. Control Eng."},{"issue":"3","key":"pone.0264631.ref018","first-page":"69","article-title":"A guide to appropriate use of Correlation coefficient in medical research","volume":"24","author":"M. Mukaka","year":"2012","journal-title":"Malawi Med. J. J. Med. Assoc. Malawi"},{"issue":"11","key":"pone.0264631.ref019","doi-asserted-by":"crossref","first-page":"e27690","DOI":"10.1371\/journal.pone.0027690","article-title":"Tumor-Derived G-CSF Facilitates Neoplastic Growth through a Granulocytic Myeloid-Derived Suppressor Cell-Dependent Mechanism","volume":"6","author":"J. D. Waight","year":"2011","journal-title":"PLOS ONE"},{"issue":"50","key":"pone.0264631.ref020","doi-asserted-by":"crossref","first-page":"21248","DOI":"10.1073\/pnas.1015855107","article-title":"Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes","volume":"107","author":"M. Kowanetz","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"pone.0264631.ref021","doi-asserted-by":"crossref","first-page":"14979","DOI":"10.1038\/ncomms14979","article-title":"Monocytic and granulocytic myeloid derived suppressor cells differentially regulate spatiotemporal tumour plasticity during metastatic cascade","volume":"8","author":"M. Ouzounova","year":"2017","journal-title":"Nat. Commun."},{"issue":"6","key":"pone.0264631.ref022","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/ncb3355","article-title":"Oncogenic mTOR signaling recruits myeloid-derived suppressor cells to promote tumor initiation","volume":"18","author":"T. Welte","year":"2016","journal-title":"Nat. Cell Biol."},{"issue":"5","key":"pone.0264631.ref023","first-page":"2019","article-title":"The role of granulocyte colony-stimulating factor in breast cancer development: A review","volume":"21","author":"L. Liu","year":"2020","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"pone.0264631.ref024","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/bjc.2015.183","article-title":"Utility of pre-treatment neutrophil\u2013lymphocyte ratio and platelet\u2013lymphocyte ratio as prognostic factors in breast cancer","volume":"113","author":"C.-H. Koh","year":"2015","journal-title":"Br. J. Cancer"},{"issue":"11","key":"pone.0264631.ref025","doi-asserted-by":"crossref","first-page":"5882","DOI":"10.4049\/jimmunol.1201881","article-title":"IL-6 Cooperates with G-CSF To Induce Protumor Function of Neutrophils in Bone Marrow by Enhancing STAT3 Activation","volume":"190","author":"B. Yan","year":"2013","journal-title":"J. Immunol."},{"issue":"9","key":"pone.0264631.ref026","doi-asserted-by":"crossref","first-page":"11553","DOI":"10.1007\/s13277-016-5098-7","article-title":"Role of interleukin-6 in cancer progression and therapeutic resistance","volume":"37","author":"N. Kumari","year":"2016","journal-title":"Tumour Biol. J. Int. Soc. Oncodevelopmental Biol. Med."},{"issue":"11","key":"pone.0264631.ref027","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1038\/sj.bjc.6600956","article-title":"Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients","volume":"88","author":"T. Bachelot","year":"2003","journal-title":"Br. J. Cancer"},{"issue":"16","key":"pone.0264631.ref028","doi-asserted-by":"crossref","first-page":"5718","DOI":"10.1158\/1078-0432.CCR-05-0001","article-title":"Interleukin-1 and interleukin-6 gene polymorphisms and the risk of breast cancer in caucasian women","volume":"11","author":"L. A. Hefler","year":"2005","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res"},{"issue":"2","key":"pone.0264631.ref029","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.bbadis.2018.12.002","article-title":"RelA driven co-expression of CXCL13 and CXCR5 is governed by a multifaceted transcriptional program regulating breast cancer progression","volume":"1865","author":"S. Biswas","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis"},{"issue":"1","key":"pone.0264631.ref030","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12967-015-0521-1","article-title":"The expression of CXCL13 and its relation to unfavorable clinical characteristics in young breast cancer","volume":"13","author":"L. Chen","year":"2015","journal-title":"J. Transl. Med."},{"issue":"6","key":"pone.0264631.ref031","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/sj.bjc.6604621","article-title":"Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients","volume":"99","author":"J. Panse","year":"2008","journal-title":"Br. J. Cancer"},{"issue":"6","key":"pone.0264631.ref032","first-page":"9293","article-title":"Signaling via the CXCR5\/ERK pathway is mediated by CXCL13 in mice with breast cancer","volume":"15","author":"L. Xu","year":"2018","journal-title":"Oncol. Lett."},{"issue":"3","key":"pone.0264631.ref033","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/pcmedi\/pbab020","article-title":"CXCL13 expression in mouse 4T1 breast cancer microenvironment elicits antitumor immune response by regulating immune cell infiltration","volume":"4","author":"Q. Ma","year":"2021","journal-title":"Precis. Clin. Med."},{"key":"pone.0264631.ref034","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.3389\/fimmu.2020.521110","article-title":"Duality of B Cell-CXCL13 Axis in Tumor Immunology","volume":"11","author":"A. J. Rubio","year":"2020","journal-title":"Front. Immunol."},{"issue":"12","key":"pone.0264631.ref035","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.trecan.2016.10.010","article-title":"B lymphocytes and cancer: a love-hate relationship","volume":"2","author":"G. J. Yuen","year":"2016","journal-title":"Trends Cancer"},{"issue":"1","key":"pone.0264631.ref036","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.canlet.2009.03.022","article-title":"Serum CXCL13 positively correlates with prostatic disease, prostate-specific antigen and mediates prostate cancer cell invasion, integrin clustering and cell adhesion","volume":"283","author":"S. Singh","year":"2009","journal-title":"Cancer Lett."},{"issue":"7","key":"pone.0264631.ref037","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.3390\/ijms20071631","article-title":"PD-L1 Expression in Systemic Immune Cell Populations as a Potential Predictive Biomarker of Responses to PD-L1\/PD-1 Blockade Therapy in Lung Cancer","volume":"20","author":"A. Bocanegra","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"pone.0264631.ref038","doi-asserted-by":"crossref","first-page":"33123","DOI":"10.1038\/srep33123","article-title":"Chemokine CXCL1 mediated neutrophil recruitment: Role of glycosaminoglycan interactions","volume":"6","author":"K. V. Sawant","year":"2016","journal-title":"Sci. Rep."},{"issue":"13","key":"pone.0264631.ref039","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1158\/0008-5472.CAN-16-3199","article-title":"CXCL1 Is Critical for Premetastatic Niche Formation and Metastasis in Colorectal Cancer","volume":"77","author":"D. Wang","year":"2017","journal-title":"Cancer Res."},{"issue":"1","key":"pone.0264631.ref040","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cyto.2011.10.019","article-title":"Down-regulation of CXCL1 inhibits tumor growth in colorectal liver metastasis","volume":"57","author":"O. R. Bandapalli","year":"2012","journal-title":"Cytokine"},{"issue":"1","key":"pone.0264631.ref041","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s12967-015-0555-4","article-title":"The prognostic significance of CXCL1 hypersecretion by human colorectal cancer epithelia and myofibroblasts","volume":"13","author":"A.-F. le Rolle","year":"2015","journal-title":"J. Transl. Med."},{"issue":"9","key":"pone.0264631.ref042","doi-asserted-by":"crossref","first-page":"e1470729","DOI":"10.1080\/2162402X.2018.1470729","article-title":"Recruitment of CCR2+ tumor associated macrophage to sites of liver metastasis confers a poor prognosis in human colorectal cancer","volume":"7","author":"J. G. Grossman","year":"2018","journal-title":"Oncoimmunology"},{"issue":"2","key":"pone.0264631.ref043","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.celrep.2015.06.024","article-title":"CCL2 Promotes Colorectal Carcinogenesis by Enhancing Polymorphonuclear Myeloid-Derived Suppressor Cell Population and Function","volume":"12","author":"E. Chun","year":"2015","journal-title":"Cell Rep."},{"issue":"20","key":"pone.0264631.ref044","doi-asserted-by":"crossref","first-page":"E7619","DOI":"10.3390\/ijms21207619","article-title":"CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of Receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligands","volume":"21","author":"J. Korbecki","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"pone.0264631.ref045","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1002\/ijc.22908","article-title":"CC-chemokine ligand 17 gene therapy induces tumor regression through augmentation of tumor-infiltrating immune cells in a murine model of preexisting CT26 colon carcinoma","volume":"121","author":"N. Kanagawa","year":"2007","journal-title":"Int. J. Cancer"},{"issue":"9","key":"pone.0264631.ref046","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00262-015-1714-4","article-title":"Increased CCL17 serum levels are associated with improved survival in advanced melanoma","volume":"64","author":"B. Weide","year":"2015","journal-title":"Cancer Immunol. Immunother. CII"},{"issue":"5","key":"pone.0264631.ref047","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/ijc.28770","article-title":"Neutrophils recruit regulatory T-cells into tumors via secretion of CCL17\u2014a new mechanism of impaired antitumor immunity","volume":"135","author":"I. Mishalian","year":"2014","journal-title":"Int. J. Cancer"},{"issue":"10","key":"pone.0264631.ref048","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1002\/ijc.23392","article-title":"CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer","volume":"122","author":"Y. Mizukami","year":"2008","journal-title":"Int. J. Cancer"},{"key":"pone.0264631.ref049","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cyto.2018.02.012","article-title":"Chemokines beyond chemo-attraction: CXCL10 and its significant role in cancer and autoimmunity","volume":"109","author":"N. Karin","year":"2018","journal-title":"Cytokine"},{"issue":"9","key":"pone.0264631.ref050","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1007\/s12094-020-02299-6","article-title":"Prognostic and predictive values of CXCL10 in colorectal cancer","volume":"22","author":"J. Chen","year":"2020","journal-title":"Clin. Transl. Oncol."},{"issue":"2","key":"pone.0264631.ref051","doi-asserted-by":"crossref","first-page":"252","DOI":"10.4103\/0973-1482.199448","article-title":"Dual association of serum interleukin-10 levels with colorectal cancer","volume":"13","author":"S. Abtahi","year":"2017","journal-title":"J. Cancer Res. Ther."},{"issue":"2","key":"pone.0264631.ref052","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/JLB.4RI0818-311R","article-title":"Monocyte heterogeneity and functions in cancer","volume":"106","author":"C. E. Olingy","year":"2019","journal-title":"J. Leukoc. Biol."},{"issue":"2","key":"pone.0264631.ref053","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/cei.12579","article-title":"CXCL10 induces the recruitment of monocyte-derived macrophages into kidney, which aggravate puromycin aminonucleoside nephrosis","volume":"180","author":"D. Petrovic-Djergovic","year":"2015","journal-title":"Clin. Exp. Immunol."},{"issue":"2","key":"pone.0264631.ref054","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1158\/1078-0432.CCR-19-1868","article-title":"Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade","volume":"26","author":"I. G. House","year":"2020","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res"},{"issue":"11","key":"pone.0264631.ref055","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1158\/2159-8290.CD-18-0044","article-title":"Mouse Models for Cancer Immunotherapy Research","volume":"8","author":"B. Olson","year":"2018","journal-title":"Cancer Discov."},{"issue":"12","key":"pone.0264631.ref056","doi-asserted-by":"crossref","DOI":"10.1038\/nrc.2017.92","article-title":"Preclinical mouse solid tumour models: status quo, challenges and perspectives","volume":"17","author":"N. Gengenbacher","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"6024","key":"pone.0264631.ref057","doi-asserted-by":"crossref","DOI":"10.1126\/science.1203486","article-title":"Cancer Immunoediting: Integrating Immunity\u2019s Roles in Cancer Suppression and Promotion","volume":"331","author":"R. D. Schreiber","year":"2011","journal-title":"Science"},{"issue":"6","key":"pone.0264631.ref058","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nm1405","article-title":"Eradication of established tumors in mice by a combination antibody-based therapy","volume":"12","author":"T. Uno","year":"2006","journal-title":"Nat. Med."},{"issue":"9","key":"pone.0264631.ref059","first-page":"2145","article-title":"Intradermal injection, as opposed to subcutaneous injection, enhances immunogenicity and suppresses tumorigenicity of tumor cells","volume":"63","author":"B. Bonnotte","year":"2003","journal-title":"Cancer Res."},{"issue":"2","key":"pone.0264631.ref060","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ccr.2010.12.021","article-title":"A functional role for tumor cell heterogeneity in a mouse model of small cell lung cancer","volume":"19","author":"J. Calbo","year":"2011","journal-title":"Cancer Cell"},{"issue":"5","key":"pone.0264631.ref061","doi-asserted-by":"crossref","first-page":"651","DOI":"10.7150\/ijbs.7.651","article-title":"Dual roles of immune cells and their factors in cancer development and progression","volume":"7","author":"B. F. Zamarron","year":"2011","journal-title":"Int. J. Biol. Sci."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0264631","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T18:29:34Z","timestamp":1646072974000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0264631"}},"subtitle":[],"editor":[{"given":"Afsheen","family":"Raza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,2,28]]},"references-count":61,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0264631","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,28]]}}}